How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
An Exploratory Study of 68Ga-DOTA-SEMA in Preoperative Precise Imaging of Patients With Glucagon-Like Peptide-1 Receptor (GLP1R) Positive Insulinomas
Description:
Traditional imaging techniques for insulinomas have a low detection rate. This study aims to evaluate the safety, internal radiation dosimetry, and targeted imaging capability of the novel GLP1R imaging agent, 68Ga-DOTA-SEMA, in patients with GLP1R-positive insulinomas.
Sponsor:
The Affiliated Hospital of Southwest Medical University
Contacts:
Xie Yangxy114330@163.com
15183071089
Government Study Link:
NCT06759740 - Click here to see study onClinicalTrials.gov
68Ga-DOTA-SEMA
Isotope(s):
Target(s):
- Glucagon-Like Peptide-1 Receptor (GLP1R)
Chelator: DOTA
